分期1a期比交好，應該是沒查到與腎癌有關的基因突變，總的來說樂觀

來源: 5678910 於 2023-02-01 04:58:16 [] [舊帖] [給我悄悄話] 閱讀數 : (4146 bytes)
本帖於 2023-02-01 05:03:38 時間, 由普通用戶 5678910 編輯

The five-year survival rate of papillary renal cell carcinoma(PRCC) has been reported as 82-90%, which is slightly higher than that of other kidney cancers.[45] The reduced survival rate has been positively correlated to several factors, which are high nuclear grade and stage, vascular invasion, DNA aneuploidy, and more.[46] Patients with type 1 PRCC have significantly improved survival rates than those with type 2, which is a reflection of its lower TNM stage with a well-encapsulated tumor.[47] Compared to other common types of RCC, PRCC exhibits a relatively lower risk of tumor recurrence and cancer-related death after nephrectomy.[48] Specifically, the cancer-specific survival rate at five years following surgery with PRCC has reached up to 91%, while clear cell RCC and chromophobe RCC were 72% and 88%, respectively.[46]

請您先登陸，再發跟帖！